vs
Amarin Corp plc（AMRN）与Planet Labs PBC（PL）财务数据对比。点击上方公司名可切换其他公司
Planet Labs PBC的季度营收约是Amarin Corp plc的1.8倍（$81.3M vs $45.1M），Amarin Corp plc净利率更高（-23.3% vs -72.8%，领先49.6%），Planet Labs PBC同比增速更快（32.6% vs 7.0%），过去两年Planet Labs PBC的营收复合增速更高（17.5% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
Planet Labs PBC（常简称为Planet）是总部位于美国加利福尼亚州旧金山的上市地球影像企业，核心目标是实现全球范围的每日成像，以此监测地表变化、精准识别相关趋势，为多行业的地理数据分析需求提供可靠的数据支持。
AMRN vs PL — 直观对比
营收规模更大
PL
是对方的1.8倍
$45.1M
营收增速更快
PL
高出25.6%
7.0%
净利率更高
AMRN
高出49.6%
-72.8%
两年增速更快
PL
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $81.3M |
| 净利润 | $-10.5M | $-59.2M |
| 毛利率 | — | 57.3% |
| 营业利润率 | 35.5% | -22.6% |
| 净利率 | -23.3% | -72.8% |
| 营收同比 | 7.0% | 32.6% |
| 净利润同比 | 33.0% | -194.7% |
| 每股收益（稀释后） | — | $-0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNPL
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $81.3M | ||
| Q3 25 | $49.7M | $73.4M | ||
| Q2 25 | $72.7M | $66.3M | ||
| Q1 25 | $42.0M | $61.6M | ||
| Q4 24 | $62.3M | $61.3M | ||
| Q3 24 | $42.3M | $61.1M | ||
| Q2 24 | $67.5M | $60.4M |
净利润AMRNPL
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $-59.2M | ||
| Q3 25 | $-7.7M | $-22.6M | ||
| Q2 25 | $-14.1M | $-12.6M | ||
| Q1 25 | $-15.7M | $-35.2M | ||
| Q4 24 | $-48.6M | $-20.1M | ||
| Q3 24 | $-25.1M | $-38.7M | ||
| Q2 24 | $1.5M | $-29.3M |
毛利率AMRNPL
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 57.3% | ||
| Q3 25 | 44.7% | 57.6% | ||
| Q2 25 | 69.2% | 55.2% | ||
| Q1 25 | 59.8% | 62.1% | ||
| Q4 24 | -15.4% | 61.2% | ||
| Q3 24 | 38.5% | 52.9% | ||
| Q2 24 | 63.4% | 52.4% |
营业利润率AMRNPL
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | -22.6% | ||
| Q3 25 | -22.4% | -24.5% | ||
| Q2 25 | -22.0% | -34.4% | ||
| Q1 25 | -39.9% | -31.5% | ||
| Q4 24 | -84.3% | -36.9% | ||
| Q3 24 | -59.5% | -64.8% | ||
| Q2 24 | -0.8% | -57.2% |
净利率AMRNPL
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | -72.8% | ||
| Q3 25 | -15.6% | -30.8% | ||
| Q2 25 | -19.4% | -19.1% | ||
| Q1 25 | -37.4% | -57.1% | ||
| Q4 24 | -78.0% | -32.8% | ||
| Q3 24 | -59.4% | -63.3% | ||
| Q2 24 | 2.3% | -48.5% |
每股收益（稀释后）AMRNPL
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $-0.19 | ||
| Q3 25 | $-0.02 | $-0.07 | ||
| Q2 25 | $-0.03 | $-0.04 | ||
| Q1 25 | $-0.04 | $-0.12 | ||
| Q4 24 | $-0.12 | $-0.07 | ||
| Q3 24 | $-0.06 | $-0.13 | ||
| Q2 24 | $0.00 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $443.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $349.6M |
| 总资产 | $645.8M | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNPL
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $443.3M | ||
| Q3 25 | $286.6M | $181.1M | ||
| Q2 25 | $298.7M | $133.5M | ||
| Q1 25 | $281.8M | $118.0M | ||
| Q4 24 | $294.2M | $139.0M | ||
| Q3 24 | $305.7M | $148.3M | ||
| Q2 24 | $306.7M | $107.4M |
股东权益AMRNPL
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $349.6M | ||
| Q3 25 | $458.9M | $435.7M | ||
| Q2 25 | $464.9M | $444.8M | ||
| Q1 25 | $473.7M | $441.3M | ||
| Q4 24 | $486.2M | $464.6M | ||
| Q3 24 | $531.4M | $473.2M | ||
| Q2 24 | $551.9M | $500.3M |
总资产AMRNPL
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $1.1B | ||
| Q3 25 | $659.8M | $696.4M | ||
| Q2 25 | $670.1M | $658.4M | ||
| Q1 25 | $655.7M | $633.8M | ||
| Q4 24 | $685.3M | $630.8M | ||
| Q3 24 | $750.6M | $658.4M | ||
| Q2 24 | $799.9M | $674.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $28.6M |
| 自由现金流经营现金流 - 资本支出 | — | $1.9M |
| 自由现金流率自由现金流/营收 | — | 2.3% |
| 资本支出强度资本支出/营收 | — | 32.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $40.7M |
8季度趋势，按日历期对齐
经营现金流AMRNPL
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $28.6M | ||
| Q3 25 | $-12.7M | $67.8M | ||
| Q2 25 | $16.6M | $17.3M | ||
| Q1 25 | $-12.5M | $-6.3M | ||
| Q4 24 | $-13.3M | $4.1M | ||
| Q3 24 | $-2.4M | $-7.9M | ||
| Q2 24 | $-2.7M | $-4.3M |
自由现金流AMRNPL
| Q1 26 | — | — | ||
| Q4 25 | — | $1.9M | ||
| Q3 25 | — | $47.5M | ||
| Q2 25 | — | $9.2M | ||
| Q1 25 | — | $-17.9M | ||
| Q4 24 | — | $-3.6M | ||
| Q3 24 | — | $-23.0M | ||
| Q2 24 | — | $-14.2M |
自由现金流率AMRNPL
| Q1 26 | — | — | ||
| Q4 25 | — | 2.3% | ||
| Q3 25 | — | 64.7% | ||
| Q2 25 | — | 13.9% | ||
| Q1 25 | — | -29.1% | ||
| Q4 24 | — | -5.8% | ||
| Q3 24 | — | -37.6% | ||
| Q2 24 | — | -23.6% |
资本支出强度AMRNPL
| Q1 26 | — | — | ||
| Q4 25 | — | 32.9% | ||
| Q3 25 | — | 27.6% | ||
| Q2 25 | — | 12.3% | ||
| Q1 25 | — | 18.9% | ||
| Q4 24 | — | 12.5% | ||
| Q3 24 | — | 24.8% | ||
| Q2 24 | — | 16.4% |
现金转化率AMRNPL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
PL
| Defense And Intelligence | $49.4M | 61% |
| Civil Government | $18.8M | 23% |
| Commercial | $13.1M | 16% |
